A specialist in rare disease drug launches, Cambridge BioMarketing has been snapped up by an Irish healthcare service provider UDG Healthcare in a $35 million deal. Buying the Massachusetts-based ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, the world’s leading rare disease and specialty communications agency, announced its #SupportTheSearch social media campaign to raise ...
Yahoo Finance: UCB and VMS BioMarketing Win Gold for Persistence/Adherence Program in the PM360 Trailblazer Awards for 2021
INDIANAPOLIS, Nov. 02, 2021 (GLOBE NEWSWIRE) -- UCB and VMS BioMarketing have been selected by PM360, a leading trade magazine for marketing decision makers in the biopharma industry, as the gold ...
UCB and VMS BioMarketing Win Gold for Persistence/Adherence Program in the PM360 Trailblazer Awards for 2021
VMS BioMarketing - a leading provider of nurse-led patient and HCP engagement solutions for the biopharma industry - announced today that Jennifer Wilson has joined the company as Chief Financial ...
After two years of flat results following a huge gain in 2015, Cambridge BioMarketing began laying the groundwork for a new ascent. The biggest-picture news came when it was acquired last July for $35 ...
Business Wire: Cambridge BioMarketing Strengthens Leadership Team with Appointment of Ben Beckley as President
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cambridge BioMarketing, an Ashfield company, part of UDG Healthcare plc and the world’s leading rare disease agency, today announced the appointment of Ben Beckley ...
Cambridge BioMarketing Strengthens Leadership Team with Appointment of Ben Beckley as President
Another Rare Disease Day, another rare-disease marketing campaign from Cambridge BioMarketing. This time, the specialty ad agency built on previous years with a new podcast series that reinforces the ...